Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
0°
Mostly Cloudy
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Archives
Best of 2024
Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Chimerix, Inc. - Common Stock
(NQ:
CMRX
)
4.380
-0.180 (-3.95%)
Streaming Delayed Price
Updated: 4:00 PM EST, Feb 14, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Chimerix, Inc. - Common Stock
< Previous
1
2
3
4
5
6
Next >
Chimerix Appoints Marc D. Kozin to Board of Directors
March 21, 2024
Veteran Industry Executive Brings More Than 35 Years of Corporate Strategy Experience
From
Chimerix, Inc.
Via
GlobeNewswire
Chimerix Reports Fourth Quarter and Year End 2023 Financial Results and Provides Operational Update
February 29, 2024
From
Chimerix, Inc.
Via
GlobeNewswire
Earnings Scheduled For February 29, 2024
February 29, 2024
Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on revenue of $276.19 million.
Via
Benzinga
Preview: Chimerix's Earnings
February 28, 2024
Via
Benzinga
Chimerix to Present at TD Cowen 44th Annual Health Care Conference
February 27, 2024
From
Chimerix, Inc.
Via
GlobeNewswire
Earnings Outlook For Chimerix
November 01, 2023
Via
Benzinga
4 Analysts Have This to Say About Chimerix
August 17, 2023
Via
Benzinga
A Look Into Healthcare Sector Value Stocks
May 22, 2023
Via
Benzinga
Chimerix to Report Fourth Quarter and Year End 2023 Financial Results and Provide an Operational Update on February 29, 2024
February 22, 2024
From
Chimerix, Inc.
Via
GlobeNewswire
Chimerix Appoints Lisa Decker to Board of Directors
December 29, 2023
Seasoned Industry Executive Brings More Than 25 Years of Leadership and Business Development Experience
From
Chimerix, Inc.
Via
GlobeNewswire
Chimerix Promotes Michelle LaSpaluto to Chief Financial Officer
December 04, 2023
Proven Leader Brings More Than 25 Years of Financial Experience
From
Chimerix, Inc.
Via
GlobeNewswire
Chimerix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
November 24, 2023
From
Chimerix, Inc.
Via
GlobeNewswire
Chimerix Strengthens Executive Leadership Team with Appointment of Thomas Riga as Chief Operating and Commercial Officer
November 16, 2023
Seasoned Executive Brings More Than 25 Years of Industry Leadership Experience in Oncology Commercialization and Corporate Business Development
From
Chimerix, Inc.
Via
GlobeNewswire
Chimerix Reports Third Quarter 2023 Financial Results and Provides Operational Update
November 02, 2023
From
Chimerix, Inc.
Via
GlobeNewswire
Chimerix to Report Third Quarter 2023 Financial Results and Provide an Operational Update on November 2, 2023
October 26, 2023
From
Chimerix, Inc.
Via
GlobeNewswire
NetSol Technologies And 2 Other Stocks Under $2 Insiders Are Buying
September 27, 2023
The Dow Jones closed lower by around 388 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Overview Of Value Stocks In The Healthcare Sector
September 18, 2023
Via
Benzinga
Chimerix to Participate in Upcoming Investor Conferences
September 05, 2023
From
Chimerix, Inc.
Via
GlobeNewswire
Chimerix Announces Data Highlighting Clinical Efficacy and Molecular Mechanisms of Response to ONC201 Treatment of H3 K27M-Mutant Diffuse Midline Gliomas Published in "Cancer Discovery"
August 16, 2023
From
Chimerix, Inc.
Via
GlobeNewswire
CMRX Stock Warning! Smart Biotech Investors Will Avoid Chimerix Like the Plague.
August 11, 2023
CMRX stock may seem like a high-risk, high-potential play, but it makes sense why the market has bid down this biotech.
Via
InvestorPlace
Chimerix Reports Second Quarter 2023 Financial Results and Provides Operational Update
August 03, 2023
From
Chimerix, Inc.
Via
GlobeNewswire
7 Millionaire-Maker Penny Stocks to Buy Before the Window Closes
July 30, 2023
Although speculative trades are not for everyone, these millionaire-maker penny stocks could turn small bets into big returns.
Via
InvestorPlace
Chimerix to Report Second Quarter 2023 Financial Results and Provide an Operational Update on August 3, 2023
July 27, 2023
From
Chimerix, Inc.
Via
GlobeNewswire
7 Small-Cap Stocks to Buy Before the Breakout
July 27, 2023
If you don’t mind the extreme risks involved, growth investors should target these ideas for best small cap stocks to buy.
Via
InvestorPlace
Why These 7 Stocks Are the Best Ways to Play Biotech Right Now
July 11, 2023
With biotech stocks offering myriad viable opportunities irrespective of broader conditions, this sector is worth a closer look.
Via
InvestorPlace
Chimerix Announces Promotion of Michael T. Andriole to President and Chief Executive Officer
June 27, 2023
From
Chimerix, Inc.
Via
GlobeNewswire
7 Deeply Undervalued Growth Stocks to Buy in June
June 01, 2023
Investors may see significant rewards betting on these best undervalued growth stocks for June.
Via
InvestorPlace
Chimerix to Participate in Fireside Chat at Jefferies Global Healthcare Conference
May 31, 2023
From
Chimerix, Inc.
Via
GlobeNewswire
Chimerix to Participate in Cancer Moonshot Brain Cancers Forum on Glioblastoma (GBM) and Diffuse Intrinsic Pontine Glioma (DIPG) at White House
May 25, 2023
Forum Aim is to Share Progress and Spur Actions to Advance the Field
From
Chimerix, Inc.
Via
GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For May 23, 2023
May 23, 2023
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.